David Fontana

David Fontana is an accomplished executive with extensive experience in the biopharmaceutical industry. Currently serving as COO and CBO at Umoja Biopharma, David has held leadership roles at prominent companies including Bristol Myers Squibb and Juno Therapeutics, where David was Vice President of the Cell Therapy Franchise. David also led Strategic Alliances and was the JCAR017 Program Lead at Juno Therapeutics, Inc. Previously, David held the position of Vice President of Immuno-Oncology at Pfizer and served as Vice President and ADCETRIS Program Director at Seattle Genetics.